IMMUNOVA THERAPEUTICS LLC
MONROVIA, California
Total Received
$4.0M
Total Awards
2
State
California
Last Updated
Aug 6, 2025
Yearly Funding Trend
$2.0M24
$2.0M25
Top 2 Awards to IMMUNOVA THERAPEUTICS LLC
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through August 6, 2025.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_R44CA295183_075 DEVELOPMENT OF CD4 TCR-ENGINEERED T CELL IMMUNOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCER - ABSTRACT BREAST CANCER IS A LEADING CAUSE OF CANCER-RELATED DEATHS OF WOMEN IN THE UNITED… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | MONROVIA, CA-31 | 2024 | $2,000,000 |
ASST_NON_R44CA275489_075 DEVELOPMENT OF A THERAPEUTIC SAPNANO-ESO VACCINE FOR PROSTATE CANCER - PROJECT SUMMARY/ABSTRACT PROSTATE CANCER IS A LEADING CAUSE OF CANCER-RELATED DEATHS OF MEN IN THE UNITED ST… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | CA-90 | 2025 | $2,000,000 |
Top 2 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Federal Programs (CFDA)
View All→Source: USAspending.gov · All Recipients · California